English | 简体中文 | 繁體中文 | 한국어
 All Press Releases
 Medicine Healthcare & Pharm
雅各臣公布二零二三财年中期业绩
Nov 25, 2022 21:23 HKT
雅各臣公佈二零二三財年中期業績
Nov 25, 2022 21:22 HKT
Jacobson Pharma Announces FY2023 Interim Results
Nov 25, 2022 21:21 HKT
医思健康公布2022/23年度中期业绩 医疗服务业务推动收入同比增长31.1%
Nov 24, 2022 13:04 HKT
醫思健康公佈2022/23年度中期業績 醫療服務業務推動收入同比增長31.1%
Nov 24, 2022 13:03 HKT
EC Healthcare Announces FY2022/23 Interim Results, Revenue Increased 31.1% YoY Mainly Driven by Medical Services
Nov 24, 2022 13:02 HKT
完美医疗公布2022/23中期业绩
Nov 23, 2022 17:32 HKT
完美醫療公佈2022/23中期業績
Nov 23, 2022 17:31 HKT
Malaysian Genomics Sees Rise in Profit Margins for 1Q
Nov 23, 2022 17:30 HKT
Perfect Medical Announces Interim Results for FY2022/23
Nov 23, 2022 17:30 HKT
佈局全球,深入歐洲,新光維醫療MEDICA 2022展會圓滿結束
Nov 21, 2022 11:08 HKT
布局全球,深入欧洲,新光维医疗MEDICA 2022展会圆满结束
Nov 21, 2022 11:07 HKT
L'Oreal Groupe, together with Hotel Shilla and Anchor Equity Partners, launches SHIHYO, a newly created luxury beauty brand
Nov 21, 2022 08:00 HKT
China Medical System (867.HK) S&P Global CSA Score Achieved Significant Improvement, Leading the Industry Globally
Nov 18, 2022 20:00 HKT
CRO业务收入可观,模式动物新应用或成为百奥赛图业务增长新动能
Nov 17, 2022 13:02 HKT
CRO業務收入可觀,模式動物新應用或成為百奧賽圖業務增長新動能
Nov 17, 2022 13:01 HKT
AJG Publishes Data from HighTide Therapeutics' Phase 2 Study of HTD1801 Treatment in Primary Sclerosing Cholangitis
Nov 17, 2022 08:00 HKT
American Journal of Gastroenterology Publishes Data from HighTide Therapeutics' Phase 2 Study of HTD1801 Treatment in Primary Sclerosing Cholangitis
Nov 16, 2022 23:00 HKT
《美國胃腸病學雜誌》發表君聖泰HTD1801 治療原發性硬化性膽管炎的臨床 II 期研究數據
Nov 16, 2022 10:01 HKT
《美国胃肠病学杂志》发表君圣泰HTD1801 治疗原发性硬化性胆管炎的临床 II 期研究数据
Nov 16, 2022 10:00 HKT
<< Previous  Next >>
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: